Global Synthetic Biology Market Outlook, 2024: Biofuels, Specialty Chemicals, Diagnostics, Pharmaceuticals, and Agriculture

News provided by

Dec 24, 2019, 07:15 ET

DUBLIN, Dec. 24, 2019 /PRNewswire/ -- The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2024.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2019 to 2024. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces is also provided.

The author examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.

The role of key strategic alliances and acquisitions from January 2018 to September 2019 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.

The report includes:

An overview of the global markets for synthetic biology
Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
Description of core synthetic biology products i.e. synthetic genes, DNA parts, chassis organisms, and synthetic cells
Information on enabling technologies such as DNA sequencing, oligonucleotides, specialty media, and bioinformatics
Knowledge about enabled technologies including biofuels, specialty chemicals, diagnostics, pharmaceuticals, and agriculture
Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
Assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
Comprehensive profiles of leading companies in the industry, including Active Motif, Bayer AG, BASF AG, Cargill Inc., Dowdupont Inc., Glaxosmithkline Plc, Merck KGAA, Novartis Pharma AG, Pfizer Inc. and Thermo Fisher Scientific Inc.

Market Insights

The synthetic biology industry is a prime growth opportunity due to several factors. First, many of the applications for synthetic biology have large addressable markets and the penetration rate is still modest; the industry will experience explosive growth as these penetration rates accelerate. Second, development of exciting new technologies is driving innovation within the industry. These technologies include ultra-high-throughput screening platforms for organism design, enzymatic DNA synthesis and novel gene editing platforms. Third, the industry is focusing on value-added products, placing less emphasis on cost-sensitive, commodity products.

Synthetic biology foundries now routinely design, build and test designer organisms capable of producing valuable end products. The workflow includes modifying the genomes of these organisms to produce just the right combination of taste and texture, as for the food industry. Designer organisms in the textile industry help achieve the right combination of strength, flexibility, weight, dimensional variability, and targeted surface and structural modification. High-value synthetic biology end products such as these are forecast to drive significant market growth in this industry.

This report provides in-depth coverage of the dynamic synthetic biology industry, including insights into its component technologies and market segments, as well as its leading participants.

The synthetic biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engines that drive the development of the synthetic biology industry. Core products and technologies, including standardized DNA parts, synthetic genes and chassis organisms, are the key tools by which cellular factories and systems produce enabled products.

Synthetic biology-enabled products (e.g., pharmaceuticals, chemicals, biofuels, agricultural, textiles, food) have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. In agriculture, synthetic biology makes it possible to produce crops with desired traits, such as pest resistance or high yields. Synthetic biology allows for the production of foods free of animal products, meeting an emerging consumer need in this industry.

Key Topics Covered

1. Introduction

Study Goals and Objectives
Reasons for Doing the Study
Contribution of the Study and for Whom
Scope and Format
Methodology
Information Sources
Geographical Breakdown

2. Summary and Highlights

3. Overview

Synthetic Biology Technologies Covered in this Report
Synthetic Biology Overview
Development Stage of Synthetic Biology
Forces Driving Synthetic Biology Market Growth
Global Markets for Synthetic Biology Products
Life Cycle Status of Products and Technologies
Synthetic Biology Industry

4. Technology Background

Introduction
Synthetic Biology Defined
Synthetic Biology History
Paradigm Shift in Biology
Synthetic Biology Technology Overview
Enabling Technologies
DNA-Synthesis and DNA-Sequencing Cost Trends
DNA-Synthesis Technologies
Microfluidic Technologies
Next-Generation Sequencing Technologies
Gene Editing
Gene Drives
Bioinformatics Technologies
Biologic Components and Integrated Systems Technologies
Synthetic DNA
BioBrick Parts
Minimal Genomes and Chassis Organisms
Enabled Products
Pathway Engineering
Research and Development Applications
Synthetic Biology and the Microbiome
Synthetic Biology in Biofuels Feedstocks
Synthetic Biology Microbiome Initiatives

5. Synthetic Biology Applications

Enabling Technologies Applications
Biologic Components and Integrated Systems Applications
Synthetic Genes
BioBrick Parts
Integrated Systems
Enabled Products Applications
Pharmaceuticals
Industrial Biotechnology Applications
Agricultural Applications
Data Storage Applications

6. Synthetic Biology Industry

Industrial Biotechnology Value Chain
Industry Structural Forces
Products and Technology Life Cycle
Sequencing Instruments Industry
Long-Read Sequencing Industry
DNA Synthesis Industry
Oligos as Therapeutics
Gene Synthesis Workflow
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Gene Editing Industry
Synthetic Biology Organism Design and Foundries Industry
Software Industry
Agriculture Industry
Consumer Products Industry
Cosmetics and Skin Care Industry
Food and Beverages Industry
Healthcare Industry
Industrial Chemicals Industry
Cell-Free Systems Industry
Industry Acquisitions and Strategic Alliances

7. Synthetic Biology Markets

Industry Growth-Driving Forces
DNA Read, Write and Edit Technologies
Growing Role of Designer Organisms
Speeding up of Commercialization Pathways
Growth in Synthetic Biology Foundries
Synthetic Biology Markets by End-User Industry
Research Market
Healthcare Market
Industrial Chemicals Market
Agriculture Market
Consumer Market
Food and Beverage Market
Synthetic Biology Markets by Product Type
Enabling Products Markets
Biologic Components Market
Integrated Systems Market
Enabled Product Markets
Sources of Competitive Advantage
Healthcare Market
Consumer Products Market
Food and Beverage Market
Chemicals Market
Agriculture Market
Geographic Markets
Synthetic Biology Products by Region
Enabling Products Market by Region
Core Products Market by Region
Enabled Products Market by Region

8. Patents

Introduction
Foundational Patents
Synthetic Biology Industry Patent Analysis
Sequencing-Related Patent Issues
Gene editing-Related Patents
Gene Editing Patents: Sangamo Case Study

9. Company Profiles

20N Labs Inc.
Abeona Therapeutics Llc
Active Motif
Aemetis Inc.
Agilent Technologies Inc.
Agrimetis Llc
Agrivida Inc.
Ajinomoto Co. Inc.
Algenuity
Ambrx Inc.
Amfora Inc.
Amyris Inc.
Ansa Biotechnologies Inc.
Antheia Inc.
Arbor Biotechnologies Inc.
Arcadia Biosciences Inc.
Arcturus Therapeutics Inc.
Ardra Bio Inc.
Arzeda Corp.
Astrazeneca Plc
ATG Biosynthetics Gmbh
Atum
Avecia
Azargen Biotechnologies Pty Ltd.
Azitra Inc.
B-Mogen Biotechnologies Inc.
BASF Ag
Bayer Ag
Beam Therapeutics Inc.
Benchling
Benson Hill Biosystems Inc.
Bio Basic Inc.
Bio S&T Inc.
Biocapital Holdings Llc.
Biocellection Inc.
Biogen Inc.
Biomax Informatics Ag
Biomx Ltd.
Bioneer Corp.
Biosyntia Aps
Bluebird Bio Inc.
Bolt Threads Inc.
Bristol-Myers Squibb Co.
Brooks Life Sciences
C-Lecta Gmhb
Calysta Inc.
Calyxt Inc.
Cargill Inc.
Caribou Biosciences Inc.
Casebia Therapeutics
Caszyme
Catalog Technologies Inc.
Celgene Corp.
Cell-Free Technology Ltd.
Cellectis Sa
Centrient Pharmaceuticals
Chain Biotechnology Ltd
Cibus Inc.
Clara Foods Co.
Codagenix Inc.
Codexis Inc.
Colorifix Ltd.
Corbion
Crispr Therapeutics Ag
Cronos Group
Crown Laboratories Inc.
Danaher Corp.
Demuris Ltd.
Desktop Genetics Ltd.
DNA Script
Dovetail Genomics Llc
Dowdupont Inc.
Edigene Corp.
Edigene Inc.
Editas Medicine Inc.
Egenesis Inc.
Eligo Bioscience Sas
Endless West
Enevolv Inc.
Epoch Life Science Inc.
Etagen Pharma
Eurofins Scientific
Evolva Sa
Evonetix
Expedeon Ag
Exxonmobil Corp.
G+Flas Life Sciences Inc.
Gc Innovation America
Gea Enzymes
Geltor Inc.
Genemed Synthesis Inc.
Generay Biotech Co. Ltd.
Genomatica
Genscript
Genus Plc
Gevo Inc.
Gilead Sciences Inc.
Ginkgo Bioworks
Glaxosmithkline Plc
Global Bioenergies
Glowee
Glycosbio Food Sciences
Glycosyn Llc
Goodyear Tire & Rubber Co.
Green Biologics Ltd.
Helixworks Technologies Ltd.
Homology Medicines Inc.
Horizon Discovery Group Plc
Huvepharma
Illumina Inc.
Impossible Foods Inc.
Industrial Microbes Inc.
Ingenza Ltd.
Inovio Pharmaceuticals Inc.
Inscripta Inc.
Intellia Therapeutics Inc.
International Business Machines
Intrexon Corp.
Joyn Bio
Kaneka Corp.
KWS Saat Se
Labgenius Ltd.
Lanzatech
Lattice Automation Inc.
LC Sciences
LCY Chemical Corp.
LGC Group
Locus Biosciences
Logicbio Therapeutics
Lumen Bioscience
Lygos Inc.
Meissa Vaccinec Inc.
Merck Kgaa
Microbyre Inc.
Microsoft Corp.
Microsynbiotix
Milis Bio Ltd.
Miraculex
Modern Meadow
Modular Genetics Inc.
Molecular Assemblies Inc.
Morphosys Ag
Motif Ingredients
New England Biolabs
Novartis Pharma Ag
Novome Biotechnologies Inc.
Novozymes A/S
Novvi Llc
Nucelis Llc
Nuclera Nucleics Ltd.
Omega Bio-Tek Inc.
Oragenics Inc.
Oxford Biomedica Plc
Oxford Genetics Ltd.
Pairwise Plants Inc.
Pfizer Inc.
Phio Pharmaceuticals Corp.
Phylogica Ltd.
Phylum Biosciences Inc.
Phytowelt Green Technologies Gmbh
Pivot Bio
Poseida Therapeutics Inc.
Precision Biosciences Inc.
Prokarium Holdings Ltd.
Promega Corp.
PTC Therapeutics, Inc.
Recombinetics, Inc.
Roquette Freres
Royal Dsm Nv
Sample6 Technologies
Sangamo Therapeutics Inc.
Sarepta Therapeutics Inc.
Scarab Genomics Llc
Senti Biosciences
SGI-DNA Inc.
Sherlock Biosciences
Shinegene Molecular Bio-Technologies Inc.
Sigma Aldrich Corp.
Silicolife Lda.
Socati Corp.
Spiber Inc.
String Bio
Sugarlogix
Synbio Technologies Inc.
Synbiobeta
Synbiota
Syngenta Ag (Chemchina)
Synlogic Therapeutics
Synpromics Ltd.
Synthace Ltd.
Synthego Corp.
Synthetic Biologics Inc.
Synthetic Genomics Inc.
Synthorx Inc.
Takara Bio
Teewinot Life Sciences Corp.
Tepha Inc.
Teselagen Biotechnology Inc.
Thermo Fisher Scientific Inc.
Tierra Biosciences
Tinctorium Bio
Toolgen
Transcriptic Inc.
Translate Bio
Triton Algae Innovations Ltd.
Tropic Biosciences Uk Ltd.
Twist Bioscience
Vedanta Biosciences
Versalis Spa
Vertex Pharmaceuticals Inc.
Vir Biotechnology Inc.
Xyphos Inc.
Yield10 Biosciences Inc.
Ziopharm Oncology, Inc.
Zymergen
Zymochem Inc.

For more information about this report visit https://www.researchandmarkets.com/r/bh890o

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets